中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
29期
136-137,138
,共3页
小儿支气管肺炎%乳糖酸阿奇霉素%阿莫西林克拉维酸钾
小兒支氣管肺炎%乳糖痠阿奇黴素%阿莫西林剋拉維痠鉀
소인지기관폐염%유당산아기매소%아막서림극랍유산갑
Infantile bronchial pneumonia%Lactose acid azithromycin%Amoxicillin clavulanic acid potassium
目的：对乳糖酸阿奇霉素治疗小儿支气管肺炎的临床疗效与安全性进行分析。方法：选取2011年3月-2013年5月本院收治的小儿支气管肺炎患者84例，随机分为对照组与观察组各42例，在常规治疗基础上，对照组给予阿莫西林克拉维酸钾治疗，观察组给予乳糖酸阿奇霉素治疗，对比两组临床疗效与不良反应发生情况。结果：观察组治疗总有效率显著高于对照组，不良反应发生率显著低于对照组（P<0.05）。结论：在小儿支气管肺炎治疗中，乳糖酸阿奇霉素具有显著临床疗效，可有效缓解患儿临床症状，大幅提高患儿生活质量，值得在临床中推广。
目的：對乳糖痠阿奇黴素治療小兒支氣管肺炎的臨床療效與安全性進行分析。方法：選取2011年3月-2013年5月本院收治的小兒支氣管肺炎患者84例，隨機分為對照組與觀察組各42例，在常規治療基礎上，對照組給予阿莫西林剋拉維痠鉀治療，觀察組給予乳糖痠阿奇黴素治療，對比兩組臨床療效與不良反應髮生情況。結果：觀察組治療總有效率顯著高于對照組，不良反應髮生率顯著低于對照組（P<0.05）。結論：在小兒支氣管肺炎治療中，乳糖痠阿奇黴素具有顯著臨床療效，可有效緩解患兒臨床癥狀，大幅提高患兒生活質量，值得在臨床中推廣。
목적：대유당산아기매소치료소인지기관폐염적림상료효여안전성진행분석。방법：선취2011년3월-2013년5월본원수치적소인지기관폐염환자84례，수궤분위대조조여관찰조각42례，재상규치료기출상，대조조급여아막서림극랍유산갑치료，관찰조급여유당산아기매소치료，대비량조림상료효여불량반응발생정황。결과：관찰조치료총유효솔현저고우대조조，불량반응발생솔현저저우대조조（P<0.05）。결론：재소인지기관폐염치료중，유당산아기매소구유현저림상료효，가유효완해환인림상증상，대폭제고환인생활질량，치득재림상중추엄。
Objective:To explore the clinical curative effect and security of the lactose acid azithromycin treats infantile bronchial pneumonia. Method:84 patients with infantile bronchopneumonia were chosen in our hospital from March 2011 to May 2011,42 cases were randomly divided into control group and treatment group,on the basis of conventional treatment,the control group was given amoxicillin clavulanic acid potassium treatment, the treatment group was given lactose acid azithromycin treatment,compared the clinical curative effect and adverse reactions of the two groups. Result:The total effective rate of the treatment group was significantly higher than control group,the incidence of adverse reactions was significantly lower than the control group(P<0.05). Conclusion:In the treatment of children who has bronchial pneumonia,lactose acid azithromycin has significant clinical effect, it can relieve clinical symptoms effectively,and can raise the quality of children’s life,is worth popularization in clinical.
